Plasminogen activator inhibitor-1 (PAI-1) is a member of the serine pr
otease inhibitor (serpin) supergene family and a central regulatory pr
otein in the blood coagulation system. PAI-1 is unique among serpins i
n exhibiting distinct active and inactive (latent) conformations in vi
vo. Though the structure of latent PAI-I was recently solved, the stru
cture of the short-lived, active form of PAI-1 is not known, In order
to probe the structural basis for this unique conformational change, a
randomly mutated recombinant PAI-1 expression library was constructed
in bacteriophage and screened for increased functional stability, Fou
rteen unique clones were selected, and shown to exhibit functional hal
f-lives (T(1/2)s) exceeding that of wild-type PAI-1 by up to 72-fold.
The most stable variant (T-1/2 = 145 h) contained four mutations. Deta
iled analysis of these four mutations, individually and in combination
, demonstrated that the markedly enhanced functional stability of the
parent compound mutant required contributions from all four substituti
ons, with no individual T-1/2 exceeding 6.6 h, The functional stabilit
y of at least eight of the remaining 13 compound mutants also required
interactions between two or more amino acid substitutions, with no si
ngle variant increasing the T-1/2 by >10-foId, The nature of the ident
ified mutations implies that the unique instability of the PAI-1 activ
e conformation evolved through global changes in protein packing and s
uggest a selective advantage for transient inhibitor function.